>
Organization
CytRx Corp. ▼
Topic
All Topics ▼
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on CytRx Corp.

CytRx Corporation Announces Conclusion of Pre-Clinical Phase for Its Albumin Binding Ultra High Potency LADR(TM) Drug Candidates and Accompanying Companion Diagnostic
December 21, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation to Present at the 11th Annual LD Micro Main Event
November 28, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation Highlights NantCell Inc's Clinical Data with Aldoxorubicin Presented at the Society for Immunotherapy of Cancer's 33rd Annual Meeting
November 8, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation Reports Third Quarter 2018 Financial Results
November 2, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corp. filed form 10-Q
November 2, 2018  •  SEC
Key Emerging Oncology Trends By Big Pharma Strengthen CytRx's Rationally Designed, Targeted Therapies Pipeline
October 31, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx to Hold Third Quarter 2018 Financial Results Conference Call and Webcast on Friday, November 2, 2018
October 29, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation to Present at the 2018 MicroCap Conference
September 25, 2018  •  PR Newswire
... PR Newswire CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation announces USD250,000 in milestone payment for arimoclomol from Orphazyme A/S
September 14, 2018  •  Global Banking News
... Biopharmaceutical company CytRx Corporation (NASDAQ:CYTR) reported on Thursday the receipt of a milestone payment of USD250,000 ...
CytRx Corporation Announces Receipt of Milestone Payment from Orphazyme A/S
September 13, 2018  •  PR Newswire
... CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/cytrx-corp-o16786
  • https://relationshipscience.com/News/cytrx-corp-o16786
Related News Feeds
Board and Executive Moves involving CytRx Corp.
Pharmaceuticals
Board and Executive Moves in Pharmaceuticals
Alumni of CytRx Corp.
Subscribe now for full coverage on CytRx Corp.
Start My Free Trial